Purpose The incidence of allergen specific immunotherapy-related systemic reactions (SRs)
varies among different studies, and many factors are likely to contribute to SRs. This study …

Background The aim of the current study is to evaluate the prevalence, severity and possible
risk factors of systemic reactions (SRs) to subcutaneous allergen immunotherapy (SCIT) in …

Background Standardized allergen-specific immunotherapy (SIT) has been used in China
for years. However, there is no extensive study of the safety of standardized SIT in Chinese …

In order to evaluate the efficacy and safety of an extract of Alternaria alternata in a paediatric
population, a two phase study plan has been elaborated that in the first place consists of a …

We performed a prospective, multicenter study to assess the tolerance and possible short-
term effects of allergen vaccines administered according to a cluster schedule in the months …

Background: In spite of allergen-specific immunotherapy (SIT) multiple benefits, its use is
restricted in some countries owing to concerns about severe adverse reactions. Objective …

Aim: A double-blind placebo-controlled study was conducted according to EMA guidelines,
to evaluate safety, tolerability and short-term treatment effects of three up-dosing regimens of …

Antecedentes: Pese a los múltiples beneficios de la inmunoterapia alérgeno-específica, en
algunos países se restringe su uso por temor a las reacciones adversas severas. Objetivo …

Wprowadzenie. Skrócenie fazy wstępnej immunoterapii umożliwia zmniejszenie liczby wizyt
oraz sprzyja większej akceptacji immunoterapii przez pacjentów i ich opiekunów. Cel pracy …

Wprowadzenie. Swoista immunoterapia jest skutecznym leczeniem IgE-zależnych chorób
alergicznych, ale niepewność dotycząca bezpieczeństwa i brak akceptacji tej terapii przez …